nodes	percent_of_prediction	percent_of_DWPC	metapath
Menadione—F7—cardiovascular system—attention deficit hyperactivity disorder	0.0272	0.0444	CbGeAlD
Menadione—F9—cardiovascular system—attention deficit hyperactivity disorder	0.026	0.0424	CbGeAlD
Menadione—VKORC1L1—midbrain—attention deficit hyperactivity disorder	0.02	0.0327	CbGeAlD
Menadione—F7—nervous system—attention deficit hyperactivity disorder	0.0175	0.0285	CbGeAlD
Menadione—F7—central nervous system—attention deficit hyperactivity disorder	0.0168	0.0274	CbGeAlD
Menadione—F9—nervous system—attention deficit hyperactivity disorder	0.0167	0.0272	CbGeAlD
Menadione—VKORC1L1—nervous system—attention deficit hyperactivity disorder	0.0165	0.0269	CbGeAlD
Menadione—F9—central nervous system—attention deficit hyperactivity disorder	0.0161	0.0262	CbGeAlD
Menadione—BGLAP—cardiovascular system—attention deficit hyperactivity disorder	0.0159	0.0259	CbGeAlD
Menadione—VKORC1L1—central nervous system—attention deficit hyperactivity disorder	0.0159	0.0259	CbGeAlD
Menadione—VKORC1L1—cerebellum—attention deficit hyperactivity disorder	0.0155	0.0253	CbGeAlD
Menadione—PROS1—cardiovascular system—attention deficit hyperactivity disorder	0.0147	0.024	CbGeAlD
Menadione—F10—cardiovascular system—attention deficit hyperactivity disorder	0.0139	0.0226	CbGeAlD
Menadione—F7—brain—attention deficit hyperactivity disorder	0.0134	0.0218	CbGeAlD
Menadione—VKORC1—cardiovascular system—attention deficit hyperactivity disorder	0.0133	0.0217	CbGeAlD
Menadione—F9—brain—attention deficit hyperactivity disorder	0.0128	0.0208	CbGeAlD
Menadione—VKORC1L1—brain—attention deficit hyperactivity disorder	0.0126	0.0205	CbGeAlD
Menadione—MTHFR—forebrain—attention deficit hyperactivity disorder	0.0117	0.0191	CbGeAlD
Menadione—PROS1—midbrain—attention deficit hyperactivity disorder	0.0115	0.0188	CbGeAlD
Menadione—MAOB—Dopamine metabolism—COMT—attention deficit hyperactivity disorder	0.0104	0.0268	CbGpPWpGaD
Menadione—MAOB—Dopamine metabolism—MAOA—attention deficit hyperactivity disorder	0.0103	0.0267	CbGpPWpGaD
Menadione—GGCX—nervous system—attention deficit hyperactivity disorder	0.00996	0.0162	CbGeAlD
Menadione—F2—cardiovascular system—attention deficit hyperactivity disorder	0.00988	0.0161	CbGeAlD
Menadione—MTHFR—cardiovascular system—attention deficit hyperactivity disorder	0.00988	0.0161	CbGeAlD
Menadione—NQO1—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00983	0.0254	CbGpPWpGaD
Menadione—NQO1—forebrain—attention deficit hyperactivity disorder	0.00974	0.0159	CbGeAlD
Menadione—MTHFR—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.00971	0.0251	CbGpPWpGaD
Menadione—GGCX—central nervous system—attention deficit hyperactivity disorder	0.00959	0.0156	CbGeAlD
Menadione—PROS1—nervous system—attention deficit hyperactivity disorder	0.00946	0.0154	CbGeAlD
Menadione—GGCX—cerebellum—attention deficit hyperactivity disorder	0.00937	0.0153	CbGeAlD
Menadione—PROS1—central nervous system—attention deficit hyperactivity disorder	0.00911	0.0149	CbGeAlD
Menadione—F2—Platelet Aggregation (Plug Formation)—ADRA2C—attention deficit hyperactivity disorder	0.00898	0.0232	CbGpPWpGaD
Menadione—PROS1—cerebellum—attention deficit hyperactivity disorder	0.0089	0.0145	CbGeAlD
Menadione—VKORC1—nervous system—attention deficit hyperactivity disorder	0.00853	0.0139	CbGeAlD
Menadione—NQO1—cardiovascular system—attention deficit hyperactivity disorder	0.00824	0.0134	CbGeAlD
Menadione—VKORC1—central nervous system—attention deficit hyperactivity disorder	0.00822	0.0134	CbGeAlD
Menadione—VKORC1—cerebellum—attention deficit hyperactivity disorder	0.00803	0.0131	CbGeAlD
Menadione—NQO2—midbrain—attention deficit hyperactivity disorder	0.00769	0.0125	CbGeAlD
Menadione—GGCX—brain—attention deficit hyperactivity disorder	0.00761	0.0124	CbGeAlD
Menadione—PROS1—brain—attention deficit hyperactivity disorder	0.00723	0.0118	CbGeAlD
Menadione—MAOB—forebrain—attention deficit hyperactivity disorder	0.00689	0.0112	CbGeAlD
Menadione—VKORC1—brain—attention deficit hyperactivity disorder	0.00652	0.0106	CbGeAlD
Menadione—NQO1—Oxidative Stress—MAOA—attention deficit hyperactivity disorder	0.00648	0.0168	CbGpPWpGaD
Menadione—NQO1—midbrain—attention deficit hyperactivity disorder	0.00643	0.0105	CbGeAlD
Menadione—MTHFR—nervous system—attention deficit hyperactivity disorder	0.00634	0.0103	CbGeAlD
Menadione—F2—nervous system—attention deficit hyperactivity disorder	0.00634	0.0103	CbGeAlD
Menadione—NQO2—nervous system—attention deficit hyperactivity disorder	0.00632	0.0103	CbGeAlD
Menadione—MTHFR—central nervous system—attention deficit hyperactivity disorder	0.00611	0.00996	CbGeAlD
Menadione—F2—central nervous system—attention deficit hyperactivity disorder	0.00611	0.00996	CbGeAlD
Menadione—MAOB—Alpha-synuclein signaling—SLC6A3—attention deficit hyperactivity disorder	0.0061	0.0158	CbGpPWpGaD
Menadione—NQO2—central nervous system—attention deficit hyperactivity disorder	0.00608	0.00993	CbGeAlD
Menadione—MTHFR—cerebellum—attention deficit hyperactivity disorder	0.00597	0.00974	CbGeAlD
Menadione—NQO2—cerebellum—attention deficit hyperactivity disorder	0.00595	0.0097	CbGeAlD
Menadione—MAOB—cardiovascular system—attention deficit hyperactivity disorder	0.00582	0.0095	CbGeAlD
Menadione—XDH—Oxidative Stress—MAOA—attention deficit hyperactivity disorder	0.00582	0.015	CbGpPWpGaD
Menadione—NQO1—nervous system—attention deficit hyperactivity disorder	0.00529	0.00863	CbGeAlD
Menadione—NQO1—central nervous system—attention deficit hyperactivity disorder	0.00509	0.00831	CbGeAlD
Menadione—NQO1—cerebellum—attention deficit hyperactivity disorder	0.00498	0.00812	CbGeAlD
Menadione—F2—brain—attention deficit hyperactivity disorder	0.00485	0.00791	CbGeAlD
Menadione—MTHFR—brain—attention deficit hyperactivity disorder	0.00485	0.00791	CbGeAlD
Menadione—NQO2—brain—attention deficit hyperactivity disorder	0.00483	0.00788	CbGeAlD
Menadione—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.00477	0.00778	CbGeAlD
Menadione—F2—Platelet Aggregation (Plug Formation)—ADRA2A—attention deficit hyperactivity disorder	0.00472	0.0122	CbGpPWpGaD
Menadione—F7—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—attention deficit hyperactivity disorder	0.00463	0.0119	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.0046	0.0119	CbGpPWpGaD
Menadione—PROS1—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00458	0.0118	CbGpPWpGaD
Menadione—AOX1—cerebellum—attention deficit hyperactivity disorder	0.00457	0.00745	CbGeAlD
Menadione—MAOB—midbrain—attention deficit hyperactivity disorder	0.00455	0.00742	CbGeAlD
Menadione—XDH—Nucleotide metabolism—DPYD—attention deficit hyperactivity disorder	0.00443	0.0114	CbGpPWpGaD
Menadione—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—attention deficit hyperactivity disorder	0.00435	0.0112	CbGpPWpGaD
Menadione—NQO1—brain—attention deficit hyperactivity disorder	0.00404	0.0066	CbGeAlD
Menadione—CYP2A6—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.0039	0.0101	CbGpPWpGaD
Menadione—CYP2A6—brain—attention deficit hyperactivity disorder	0.00387	0.00632	CbGeAlD
Menadione—MAOB—nervous system—attention deficit hyperactivity disorder	0.00374	0.0061	CbGeAlD
Menadione—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.00373	0.00609	CbGeAlD
Menadione—AOX1—brain—attention deficit hyperactivity disorder	0.00371	0.00605	CbGeAlD
Menadione—F7—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.00368	0.00949	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.00368	0.00949	CbGpPWpGaD
Menadione—F9—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00363	0.00936	CbGpPWpGaD
Menadione—MAOB—central nervous system—attention deficit hyperactivity disorder	0.0036	0.00587	CbGeAlD
Menadione—BGLAP—Notch-mediated HES/HEY network—EP300—attention deficit hyperactivity disorder	0.00359	0.00928	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00356	0.0092	CbGpPWpGaD
Menadione—MAOB—cerebellum—attention deficit hyperactivity disorder	0.00352	0.00574	CbGeAlD
Menadione—F7—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00346	0.00893	CbGpPWpGaD
Menadione—F7—Circadian Clock—EP300—attention deficit hyperactivity disorder	0.00337	0.0087	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00322	0.00832	CbGpPWpGaD
Menadione—F7—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00318	0.00822	CbGpPWpGaD
Menadione—CYP1A2—Methylation—COMT—attention deficit hyperactivity disorder	0.00297	0.00766	CbGpPWpGaD
Menadione—CYP1A1—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00291	0.00751	CbGpPWpGaD
Menadione—MAOB—brain—attention deficit hyperactivity disorder	0.00286	0.00466	CbGeAlD
Menadione—BGLAP—Regulation of retinoblastoma protein—EP300—attention deficit hyperactivity disorder	0.00274	0.00707	CbGpPWpGaD
Menadione—PROC—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00267	0.00689	CbGpPWpGaD
Menadione—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.00263	0.00428	CbGeAlD
Menadione—PROS1—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.00255	0.0066	CbGpPWpGaD
Menadione—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.00253	0.00412	CbGeAlD
Menadione—NQO1—Amino acid and derivative metabolism—TPH2—attention deficit hyperactivity disorder	0.00248	0.00641	CbGpPWpGaD
Menadione—MAOB—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00246	0.00636	CbGpPWpGaD
Menadione—NQO1—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00243	0.00628	CbGpPWpGaD
Menadione—PROS1—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00241	0.00621	CbGpPWpGaD
Menadione—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.00239	0.00391	CbGeAlD
Menadione—PROS1—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00236	0.0061	CbGpPWpGaD
Menadione—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.00231	0.00376	CbGeAlD
Menadione—BGLAP—Glucocorticoid receptor regulatory network—EP300—attention deficit hyperactivity disorder	0.0023	0.00594	CbGpPWpGaD
Menadione—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.00225	0.00368	CbGeAlD
Menadione—NQO1—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00217	0.00559	CbGpPWpGaD
Menadione—F2—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00215	0.00555	CbGpPWpGaD
Menadione—CYP1A1—brain—attention deficit hyperactivity disorder	0.00201	0.00327	CbGeAlD
Menadione—NQO1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00199	0.00514	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00199	0.00514	CbGpPWpGaD
Menadione—CYP1A1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00197	0.00509	CbGpPWpGaD
Menadione—CYP1A1—Oxidative Stress—MAOA—attention deficit hyperactivity disorder	0.00192	0.00496	CbGpPWpGaD
Menadione—F9—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.0019	0.00492	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.00187	0.00484	CbGpPWpGaD
Menadione—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00185	0.00479	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00185	0.00477	CbGpPWpGaD
Menadione—CYP2E1—brain—attention deficit hyperactivity disorder	0.00183	0.00299	CbGeAlD
Menadione—F10—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.0018	0.00465	CbGpPWpGaD
Menadione—NQO1—Validated transcriptional targets of TAp63 isoforms—EP300—attention deficit hyperactivity disorder	0.00175	0.00452	CbGpPWpGaD
Menadione—F7—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00167	0.00432	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00163	0.0042	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00159	0.00412	CbGpPWpGaD
Menadione—PROS1—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00149	0.00384	CbGpPWpGaD
Menadione—PROS1—Immune System—STUB1—attention deficit hyperactivity disorder	0.00144	0.00372	CbGpPWpGaD
Menadione—PROC—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.0014	0.00362	CbGpPWpGaD
Menadione—MAOB—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00132	0.0034	CbGpPWpGaD
Menadione—MAOB—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00131	0.00338	CbGpPWpGaD
Menadione—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00126	0.00325	CbGpPWpGaD
Menadione—PROS1—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00124	0.0032	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00124	0.0032	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00121	0.00313	CbGpPWpGaD
Menadione—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.0012	0.0031	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00119	0.00309	CbGpPWpGaD
Menadione—F2—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00113	0.00292	CbGpPWpGaD
Menadione—F2—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00111	0.00286	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.0011	0.00285	CbGpPWpGaD
Menadione—PROS1—Immune System—POLR3A—attention deficit hyperactivity disorder	0.00109	0.00282	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00104	0.0027	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.000965	0.00249	CbGpPWpGaD
Menadione—CYP2A6—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000965	0.00249	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000948	0.00245	CbGpPWpGaD
Menadione—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000948	0.00245	CbGpPWpGaD
Menadione—F10—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000945	0.00244	CbGpPWpGaD
Menadione—MTHFR—Disease—STUB1—attention deficit hyperactivity disorder	0.000907	0.00234	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000897	0.00232	CbGpPWpGaD
Menadione—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000893	0.00231	CbGpPWpGaD
Menadione—AOX1—Disease—STUB1—attention deficit hyperactivity disorder	0.000886	0.00229	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000869	0.00225	CbGpPWpGaD
Menadione—CYP2A6—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00086	0.00222	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000854	0.00221	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000844	0.00218	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000841	0.00217	CbGpPWpGaD
Menadione—F2—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000831	0.00215	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000786	0.00203	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000743	0.00192	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000735	0.0019	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0007	0.00181	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000686	0.00177	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000683	0.00177	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000662	0.00171	CbGpPWpGaD
Menadione—NQO1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000661	0.00171	CbGpPWpGaD
Menadione—MTHFR—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000652	0.00169	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000651	0.00168	CbGpPWpGaD
Menadione—F9—Hemostasis—EP300—attention deficit hyperactivity disorder	0.00065	0.00168	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000643	0.00166	CbGpPWpGaD
Menadione—CYP2A6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000641	0.00166	CbGpPWpGaD
Menadione—AOX1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000637	0.00165	CbGpPWpGaD
Menadione—CYP2A6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000637	0.00165	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000636	0.00164	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000623	0.00161	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000599	0.00155	CbGpPWpGaD
Menadione—XDH—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000592	0.00153	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000589	0.00152	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000589	0.00152	CbGpPWpGaD
Menadione—F2—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000582	0.0015	CbGpPWpGaD
Menadione—F7—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000571	0.00147	CbGpPWpGaD
Menadione—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00057	0.00147	CbGpPWpGaD
Menadione—F2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00056	0.00145	CbGpPWpGaD
Menadione—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000551	0.00142	CbGpPWpGaD
Menadione—MAOB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000538	0.00139	CbGpPWpGaD
Menadione—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.000521	0.00135	CbGpPWpGaD
Menadione—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000507	0.00131	CbGpPWpGaD
Menadione—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000503	0.0013	CbGpPWpGaD
Menadione—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0005	0.00129	CbGpPWpGaD
Menadione—PROC—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000478	0.00124	CbGpPWpGaD
Menadione—CYP1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000478	0.00123	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000475	0.00123	CbGpPWpGaD
Menadione—CYP1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000475	0.00123	CbGpPWpGaD
Menadione—CYP1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000471	0.00122	CbGpPWpGaD
Menadione—NQO1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000456	0.00118	CbGpPWpGaD
Menadione—NQO1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000456	0.00118	CbGpPWpGaD
Menadione—MTHFR—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00045	0.00116	CbGpPWpGaD
Menadione—MTHFR—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00045	0.00116	CbGpPWpGaD
Menadione—NQO1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000449	0.00116	CbGpPWpGaD
Menadione—MTHFR—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000443	0.00114	CbGpPWpGaD
Menadione—AOX1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00044	0.00114	CbGpPWpGaD
Menadione—AOX1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00044	0.00114	CbGpPWpGaD
Menadione—F2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000437	0.00113	CbGpPWpGaD
Menadione—AOX1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000433	0.00112	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000432	0.00111	CbGpPWpGaD
Menadione—MTHFR—Disease—SNAP25—attention deficit hyperactivity disorder	0.00043	0.00111	CbGpPWpGaD
Menadione—PROS1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000423	0.00109	CbGpPWpGaD
Menadione—AOX1—Disease—SNAP25—attention deficit hyperactivity disorder	0.00042	0.00108	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000419	0.00108	CbGpPWpGaD
Menadione—NQO1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000417	0.00108	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000415	0.00107	CbGpPWpGaD
Menadione—MTHFR—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000412	0.00106	CbGpPWpGaD
Menadione—XDH—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000409	0.00106	CbGpPWpGaD
Menadione—XDH—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000409	0.00106	CbGpPWpGaD
Menadione—XDH—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000402	0.00104	CbGpPWpGaD
Menadione—AOX1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000402	0.00104	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000386	0.000998	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000381	0.000984	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000377	0.000974	CbGpPWpGaD
Menadione—F2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000375	0.00097	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000375	0.00097	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000375	0.00097	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000374	0.000966	CbGpPWpGaD
Menadione—XDH—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000374	0.000966	CbGpPWpGaD
Menadione—MAOB—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000372	0.00096	CbGpPWpGaD
Menadione—MAOB—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000372	0.00096	CbGpPWpGaD
Menadione—F2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000368	0.00095	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000368	0.00095	CbGpPWpGaD
Menadione—MAOB—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000366	0.000945	CbGpPWpGaD
Menadione—NQO1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000365	0.000942	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000363	0.000938	CbGpPWpGaD
Menadione—F2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000361	0.000932	CbGpPWpGaD
Menadione—MTHFR—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00036	0.00093	CbGpPWpGaD
Menadione—AOX1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000352	0.000908	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000351	0.000906	CbGpPWpGaD
Menadione—NQO1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000347	0.000896	CbGpPWpGaD
Menadione—MTHFR—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000343	0.000885	CbGpPWpGaD
Menadione—MAOB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00034	0.000878	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00034	0.000877	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000338	0.000874	CbGpPWpGaD
Menadione—AOX1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000335	0.000865	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000334	0.000862	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00033	0.000852	CbGpPWpGaD
Menadione—XDH—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000327	0.000844	CbGpPWpGaD
Menadione—F10—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000323	0.000833	CbGpPWpGaD
Menadione—XDH—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000311	0.000804	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000307	0.000793	CbGpPWpGaD
Menadione—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000305	0.000787	CbGpPWpGaD
Menadione—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000303	0.000782	CbGpPWpGaD
Menadione—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000301	0.000776	CbGpPWpGaD
Menadione—MAOB—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000297	0.000768	CbGpPWpGaD
Menadione—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000293	0.000757	CbGpPWpGaD
Menadione—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000287	0.000741	CbGpPWpGaD
Menadione—MAOB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000283	0.000731	CbGpPWpGaD
Menadione—NQO1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000276	0.000714	CbGpPWpGaD
Menadione—NQO1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000274	0.000709	CbGpPWpGaD
Menadione—MTHFR—Metabolism—COMT—attention deficit hyperactivity disorder	0.000273	0.000705	CbGpPWpGaD
Menadione—MTHFR—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000271	0.0007	CbGpPWpGaD
Menadione—AOX1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000267	0.000688	CbGpPWpGaD
Menadione—AOX1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000265	0.000684	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000262	0.000678	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000255	0.000659	CbGpPWpGaD
Menadione—XDH—Metabolism—COMT—attention deficit hyperactivity disorder	0.000248	0.00064	CbGpPWpGaD
Menadione—XDH—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000246	0.000635	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000237	0.000612	CbGpPWpGaD
Menadione—MAOB—Metabolism—COMT—attention deficit hyperactivity disorder	0.000225	0.000582	CbGpPWpGaD
Menadione—MAOB—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000224	0.000578	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000223	0.000576	CbGpPWpGaD
Menadione—PROS1—Immune System—EP300—attention deficit hyperactivity disorder	0.000222	0.000573	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000215	0.000556	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000207	0.000535	CbGpPWpGaD
Menadione—F2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000207	0.000535	CbGpPWpGaD
Menadione—F2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000201	0.000518	CbGpPWpGaD
Menadione—F2—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000199	0.000513	CbGpPWpGaD
Menadione—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000198	0.00051	CbGpPWpGaD
Menadione—F2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000197	0.000509	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000195	0.000505	CbGpPWpGaD
Menadione—F2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000195	0.000503	CbGpPWpGaD
Menadione—F2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000181	0.000469	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000181	0.000468	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000181	0.000468	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000178	0.00046	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000166	0.000428	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000145	0.000374	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000143	0.00037	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000143	0.00037	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000141	0.000364	CbGpPWpGaD
Menadione—MTHFR—Disease—EP300—attention deficit hyperactivity disorder	0.00014	0.000361	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000138	0.000356	CbGpPWpGaD
Menadione—AOX1—Disease—EP300—attention deficit hyperactivity disorder	0.000136	0.000353	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000135	0.000348	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000135	0.000348	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000133	0.000343	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000131	0.000338	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000127	0.000328	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000125	0.000322	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000123	0.000319	CbGpPWpGaD
Menadione—NQO1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000118	0.000306	CbGpPWpGaD
Menadione—MTHFR—Metabolism—EP300—attention deficit hyperactivity disorder	0.000117	0.000302	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000114	0.000295	CbGpPWpGaD
Menadione—AOX1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000114	0.000295	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	0.00011	0.000283	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000109	0.000281	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000109	0.000281	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000108	0.000279	CbGpPWpGaD
Menadione—XDH—Metabolism—EP300—attention deficit hyperactivity disorder	0.000106	0.000274	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000103	0.000265	CbGpPWpGaD
Menadione—MAOB—Metabolism—EP300—attention deficit hyperactivity disorder	9.66e-05	0.000249	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	8.67e-05	0.000224	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.61e-05	0.000222	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	8.6e-05	0.000222	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.6e-05	0.000222	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	8.46e-05	0.000219	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	8.17e-05	0.000211	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.12e-05	0.00021	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.87e-05	0.000203	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.87e-05	0.000203	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.88e-05	0.000178	CbGpPWpGaD
Menadione—F2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.73e-05	0.000174	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.55e-05	0.000169	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	5.21e-05	0.000135	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	5.17e-05	0.000134	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.02e-05	0.00013	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	4.7e-05	0.000122	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	3.72e-05	9.6e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	3.51e-05	9.05e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	2.23e-05	5.77e-05	CbGpPWpGaD
